Can a Ceramide-Rich moisturizer beat petrolatum for aging skin?
NCT ID NCT07739355
First seen Jul 31, 2026 · Last updated Jul 31, 2026
Summary
This clinical trial compares a moisturizer containing 5% hydro-urea, ceramide, and MultiVesicular Emulsion technology against plain petrolatum for treating dry skin in people aged 60 and older. The study measures changes in skin dryness, moisture, water loss, itching, and quality of life over the treatment period. It also tracks any side effects like irritation or allergic reactions. The goal is to see if this advanced moisturizer offers better relief and comfort than the standard petrolatum ointment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- A moisturizer containing 5% hydro-urea, ceramide, and MultiVesicular Emulsion (MVE) technology
- What this could lead to
- If effective, this moisturizer could offer a more targeted, comfortable option for managing dry skin in older adults, potentially improving skin hydration and quality of life.
- What could go wrong
- The trial is small (48 participants) and early-stage, so results may not apply broadly. The moisturizer could cause irritation or allergic reactions in some users.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY SKIN IN THE ELDERLY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universitas Indonesia, Jakarta Pusat, Jakarta 10430
Jakarta Pusat, Jakarta Special Capital Region, 10430, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.